Muriel Heitsch
Karolinska Institutet
Medical Sciences
Developing a Gene Therapy for Retinitis Pigmentosa in Usher Syndrome 1F
Karolinska Institutet
Medical Sciences
Developing a Gene Therapy for Retinitis Pigmentosa in Usher Syndrome 1F
Muriel Heitsch graduated from the Bachelor’s program in Biomedicine at Karolinska Institutet, Stockholm, in June 2024. For her thesis project, she had organised an exchange semester to Harvard Medical School, Boston. Currently, Muriel is studying the Master’s program in Biomedicine at Karolinska Institutet and in parallel the online Professional MBA at the University of Colorado, Denver.
Muriel loves contributing to biomedical research, especially when it is translational, and is looking forward to starting her PhD studies after graduation.
Long term, she is very excited for a future career in biomedical science, ultimately aiming to making a difference in advancing healthcare.